These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18765129)

  • 21. Failure of PDE5 inhibitor use: a case of nonresponder? (CME).
    Chung E
    J Sex Med; 2010 Apr; 7(4 Pt 1):1321-3. PubMed ID: 20492423
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil.
    Pomara G; Morelli G; Pomara S; Taddei S; Ghiadoni L; Dinelli N; Travaglini F; Dicuio M; Mondaini N; Salvetti A; Selli C
    J Androl; 2004; 25(4):625-9. PubMed ID: 15223851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of vardenafil on blood pressure profile of patients with erectile dysfunction concomitantly treated with doxazosin gastrointestinal therapeutic system for benign prostatic hyperplasia.
    Ng CF; Wong A; Cheng CW; Chan ES; Wong HM; Hou SM
    J Urol; 2008 Sep; 180(3):1042-6. PubMed ID: 18639296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Phosphodiesterase inhibitors: effectiveness and new applications].
    van Driel MF
    Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1613-6. PubMed ID: 16901064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2009 update on phosphodiesterase type 5 inhibitor therapy part 1: Recent studies on routine dosing for penile rehabilitation, lower urinary tract symptoms, and other indications (CME).
    Shindel AW
    J Sex Med; 2009 Jul; 6(7):1794-808; quiz 1793, 1809-10. PubMed ID: 19575771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How many drugs for LUTS due to BPH are too many?
    Andersson KE
    J Urol; 2008 Sep; 180(3):811-2. PubMed ID: 18635235
    [No Abstract]   [Full Text] [Related]  

  • 27. Vardenafil--PDE5 inhibitor number 3.
    Jackson G
    Int J Clin Pract; 2004 Mar; 58(3):229. PubMed ID: 15117087
    [No Abstract]   [Full Text] [Related]  

  • 28. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of phosphodiesterase type 5 inhibitors on lower urinary tract symptoms secondary to benign prostatic hyperplasia].
    Giuliano F; Rouprêt M; Doridot G; de la Taille A
    Prog Urol; 2013 Apr; 23(5):283-95. PubMed ID: 23545003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PDE5 inhibitors for LUTS.
    Mouli S; McVary KT
    Prostate Cancer Prostatic Dis; 2009; 12(4):316-24. PubMed ID: 19687801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vardenafil: a new oral treatment for erectile dysfunction.
    Eardley I
    Int J Clin Pract; 2004 Aug; 58(8):801-6. PubMed ID: 15372854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract.
    Fibbi B; Morelli A; Vignozzi L; Filippi S; Chavalmane A; De Vita G; Marini M; Gacci M; Vannelli GB; Sandner P; Maggi M
    J Sex Med; 2010 Jan; 7(1 Pt 1):59-69. PubMed ID: 19796053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of sildenafil citrate on bladder outlet obstruction: a mouse model.
    Beamon CR; Mazar C; Salkini MW; Phull HS; Comiter CV
    BJU Int; 2009 Jul; 104(2):252-6. PubMed ID: 19154466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Mulhall JP; McLaughlin TP; Harnett JP; Scott B; Burhani S; Russell D
    J Sex Med; 2005 Nov; 2(6):848-55. PubMed ID: 16422809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vardenafil improves erectile function in men with erectile dysfunction and associated underlying conditions, irrespective of the use of concomitant medications.
    Eardley I; Lee JC; Shabsigh R; Dean J; Maggi M; Neuser D; Norenberg C
    J Sex Med; 2010 Jan; 7(1 Pt 1):244-55. PubMed ID: 20104672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies.
    Fusco F; Palmieri A; Ficarra V; Giannarini G; Novara G; Longo N; Verze P; Creta M; Mirone V
    Eur Urol; 2016 Jun; 69(6):1091-101. PubMed ID: 26831507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful use of phosphodiesterase type 5 inhibitors to control symptomatic esophageal hypercontractility: a case report.
    Agrawal A; Tutuian R; Hila A; Castell DO
    Dig Dis Sci; 2005 Nov; 50(11):2059-62. PubMed ID: 16240215
    [No Abstract]   [Full Text] [Related]  

  • 38. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?
    Doggrell S
    Int J Impot Res; 2007; 19(3):281-95. PubMed ID: 17183346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and meta-analysis.
    Yan H; Zong H; Cui Y; Li N; Zhang Y
    J Sex Med; 2014 Jun; 11(6):1539-45. PubMed ID: 24621088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphodiesterase 5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review.
    Laydner HK; Oliveira P; Oliveira CR; Makarawo TP; Andrade WS; Tannus M; Araújo JL
    BJU Int; 2011 Apr; 107(7):1104-9. PubMed ID: 20883484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.